These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
476 related items for PubMed ID: 16339513
1. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. Rosen DB, Bettadapura J, Alsharifi M, Mathew PA, Warren HS, Lanier LL. J Immunol; 2005 Dec 15; 175(12):7796-9. PubMed ID: 16339513 [Abstract] [Full Text] [Related]
2. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. Rosen DB, Cao W, Avery DT, Tangye SG, Liu YJ, Houchins JP, Lanier LL. J Immunol; 2008 May 15; 180(10):6508-17. PubMed ID: 18453569 [Abstract] [Full Text] [Related]
3. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. Aldemir H, Prod'homme V, Dumaurier MJ, Retiere C, Poupon G, Cazareth J, Bihl F, Braud VM. J Immunol; 2005 Dec 15; 175(12):7791-5. PubMed ID: 16339512 [Abstract] [Full Text] [Related]
4. A Role of NKR-P1A (CD161) and Lectin-like Transcript 1 in Natural Cytotoxicity against Human Articular Chondrocytes. Białoszewska A, Olkowska-Truchanowicz J, Bocian K, Osiecka-Iwan A, Czop A, Kieda C, Malejczyk J. J Immunol; 2018 Jan 15; 200(2):715-724. PubMed ID: 29212911 [Abstract] [Full Text] [Related]
5. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. Lanier LL, Chang C, Phillips JH. J Immunol; 1994 Sep 15; 153(6):2417-28. PubMed ID: 8077657 [Abstract] [Full Text] [Related]
8. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B. J Exp Med; 1996 Nov 01; 184(5):1845-56. PubMed ID: 8920872 [Abstract] [Full Text] [Related]
9. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. Ryan JC, Niemi EC, Nakamura MC, Seaman WE. J Exp Med; 1995 May 01; 181(5):1911-5. PubMed ID: 7722466 [Abstract] [Full Text] [Related]
10. CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver. Ishihara S, Nieda M, Kitayama J, Osada T, Yabe T, Ishikawa Y, Nagawa H, Muto T, Juji T. Eur J Immunol; 1999 Aug 01; 29(8):2406-13. PubMed ID: 10458753 [Abstract] [Full Text] [Related]
11. Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells. Yu S, Zhu Y, Chen Z, Alheim M, Ljungberg A, Zhu J. J Neurosci Res; 2002 Mar 15; 67(6):823-8. PubMed ID: 11891797 [Abstract] [Full Text] [Related]
12. The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance. Tanaka M, Fine JH, Kirkham CL, Aguilar OA, Belcheva A, Martin A, Ketela T, Moffat J, Allan DSJ, Carlyle JR. Cancer Res; 2018 Jul 01; 78(13):3589-3603. PubMed ID: 29691253 [Abstract] [Full Text] [Related]
13. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. Exley M, Porcelli S, Furman M, Garcia J, Balk S. J Exp Med; 1998 Sep 07; 188(5):867-76. PubMed ID: 9730888 [Abstract] [Full Text] [Related]
14. NKR-P1dim/TCR alpha beta + T cells and natural killer cells share expression of NKR-P1A and NKR-P1D. Appasamy PM, Kenniston TW, Brissette-Storkus CS, Chambers WH. Nat Immun; 1998 Sep 07; 15(5):259-68. PubMed ID: 9390275 [Abstract] [Full Text] [Related]
15. Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B. Li J, Rabinovich BA, Hurren R, Shannon J, Miller RG. Int Immunol; 2003 Mar 07; 15(3):411-6. PubMed ID: 12618485 [Abstract] [Full Text] [Related]
16. Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A. Kita S, Matsubara H, Kasai Y, Tamaoki T, Okabe Y, Fukuhara H, Kamishikiryo J, Krayukhina E, Uchiyama S, Ose T, Kuroki K, Maenaka K. Eur J Immunol; 2015 Jun 07; 45(6):1605-13. PubMed ID: 25826155 [Abstract] [Full Text] [Related]